Examination of IL-1 beta level as an inflammasome marker in Alzheimer's disease
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, cilt.36, sa.3, ss.141-147, 2019 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 36 Sayı: 3
- Basım Tarihi: 2019
- Doi Numarası: 10.5152/nsn.2019.10324
- Dergi Adı: NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.141-147
- Anahtar Kelimeler: Alzheimer's disease, cytokine, dementia, enzyme linked immunosorbent assay, interleukin-1 beta
- Dokuz Eylül Üniversitesi Adresli: Evet
Özet
Objective: Interleukin (IL)-1 beta is believed to be responsible for the neurotoxicity of amyloid plaques in Alzheimer's disease (AD). In the present study, serum levels of IL-1 beta, and correlations with clinical features and neuropsychiatric test results were examined.